• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS OPERATIONS, INC. COAGUCHEK TEST STRIPS; TEST, TIME, PROTHROMBIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS OPERATIONS, INC. COAGUCHEK TEST STRIPS; TEST, TIME, PROTHROMBIN Back to Search Results
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problems Hematoma (1884); Weakness (2145); Patient Problem/Medical Problem (2688)
Event Date 08/15/2018
Event Type  Injury  
Event Description
Inaccurate test strips causing hospitalization for sub-dural hematoma on (b)(6) 2018, diagnosed in july, resulting in extended hosp stay, craniotomy, icu stay and a stay in a rehabilitation facility lasting 5 weeks.Subsequent physical therapy, possible speech therapy, left side weakness, currently unk if weakness will persist after therapy.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK TEST STRIPS
Type of Device
TEST, TIME, PROTHROMBIN
Manufacturer (Section D)
ROCHE DIAGNOSTICS OPERATIONS, INC.
MDR Report Key8090726
MDR Text Key128065316
Report NumberMW5081508
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 11/16/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Was Device Available for Evaluation? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received11/19/2018
Was Device Evaluated by Manufacturer? No Information
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age71 YR
Patient Weight100
-
-